> Manufacturer control over whole gets the buy drugs and what they can do with it after that is a cornerstone of drug distribution strategy. It also maintains d

> Manufacturer control over whole gets the buy drugs and what they can do with it after that is a cornerstone of drug distribution strategy. It also maintains drug pedigree and product integrity. I can't see it going away. Not really. Manufacturers already have essentially zero control over wholesale resale within the US. (They can track it, to assist in things like recalls, but they can't prevent it). And there are other countries which already permit free trade of US-produced pharmaceuticals between their own international borders. The only difference is that it can't cross the US border again, which is why the easiest way for manufacturers to make money is to price-gouge US customers.